DENVER - A new treatment for patients with early stage breast cancer may become the standard of care.
Rose Medical Center comprehensive Breast Center in Denver is one of the first hospitals in the nation to offer the Novilase ILT, a non-surgical treatment for benign (non-cancerous) breast tumors. Novilase ILT provides a minimally invasive alternative to a surgical lumpectomy to remove tumors.
Novilase ILT is an image-guided laser ablation device that can be used in an outpatient setting. The procedure is typically completed in about an hour, only requires two small nicks, which are closed with Band-Aids, and uses a laser to heat the tumor until it dissolves. The Novilase procedure is shorter and less invasive in comparison to a lumpectomy, which requires sedation, lasts more than an hour, and includes a 2 to 3 inch incision that is closed with sutures.
Novian Health, developer of the therapy, has started a multicenter clinical trial using the laser for the destruction of malignant breast tumors. The Rise Breast Center is the first to participate in the study under the direction of Dr. Barbara Schwartzberg.
More than 600,000 lumpectomies are performed in the United States every year, including both malignant and benign tumors. The trial is registered on http://www.clinicaltrials.gov/.
To find out if you are a candidate for the trial call 303-320-2578. Or go to http://www.rosemed.com/conditions_we_treat/womens_health_care/breast_center/novilase-treatment.htm
(KUSA-TV © 2013 Multimedia Holdings Corporation)